Intralesional Chemotherapy for Kaposi’s Sarcoma

Abstract
Over a period of 36 months we treated 12 patients with skin localizations of Kaposi’s sarcoma with intralesional chemotherapy. Local administration of vincristine (usual dose 0.1 mg per site) or bleomycin appeared to be very effective: in 93 injected nodules we obtained 74 complete and 19 partial regressions. No significant local or systemic toxicity has so far been observed.

This publication has 1 reference indexed in Scilit: